766 related articles for article (PubMed ID: 7589484)
1. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
2. Selective drug efflux in multidrug-resistant immunoblastic B lymphoma cells with overexpressed P-glycoprotein.
Chao CC
Environ Toxicol Pharmacol; 1996 Feb; 1(1):63-72. PubMed ID: 21781664
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
Chao CC
Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin.
Lee WP; Lee CL; Kao MC
Biochem Biophys Res Commun; 1992 Nov; 189(1):92-100. PubMed ID: 1360209
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
6. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.
Stein U; Walther W; Lemm M; Naundorf H; Fichtner I
Int J Cancer; 1997 Sep; 72(5):885-91. PubMed ID: 9311609
[TBL] [Abstract][Full Text] [Related]
7. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
[TBL] [Abstract][Full Text] [Related]
8. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
9. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
Ades S; Maxfield LF; Gould CJ; Jones GK; Levy SB
Int J Oncol; 2006 Mar; 28(3):747-53. PubMed ID: 16465381
[TBL] [Abstract][Full Text] [Related]
10. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
[TBL] [Abstract][Full Text] [Related]
11. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
Cleary I; Doherty G; Moran E; Clynes M
Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
13. Adriamycin-inducible proteins associated with drug sensitivity in resistant immunoblastic B lymphoma cells.
Chao CC; Yam WC; Chung KC; Ho YS
Mutat Res; 1995 Jan; 346(1):33-41. PubMed ID: 7530327
[TBL] [Abstract][Full Text] [Related]
14. Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein.
Sumizawa T; Chuman Y; Sakamoto H; Iemura K; Almquist KC; Deeley RG; Cole SP; Akiyama S
Somat Cell Mol Genet; 1994 Sep; 20(5):423-35. PubMed ID: 7825064
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells.
Abe T; Hasegawa S; Taniguchi K; Yokomizo A; Kuwano T; Ono M; Mori T; Hori S; Kohno K; Kuwano M
Int J Cancer; 1994 Sep; 58(6):860-4. PubMed ID: 7927879
[TBL] [Abstract][Full Text] [Related]
16. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
[TBL] [Abstract][Full Text] [Related]
17. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
[TBL] [Abstract][Full Text] [Related]
18. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase and glutathione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells.
Lee WP; Lee CL; Lin HC
Cancer Chemother Pharmacol; 1996; 38(1):45-51. PubMed ID: 8603451
[TBL] [Abstract][Full Text] [Related]
20. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
Chiang CD; Song EJ; Yang VC; Chao CC
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]